Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion (PRAISE)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a prospective, multi-center, randomized, crossover trial to evaluate the clinical effectiveness of red blood cells (RBCs) derived from Mirasol-treated whole blood (WB) versus conventional RBCs in transfusion dependent thalassemia patients. Throughout the clinical study, RBC transfusion volume and frequency will be determined by each subject\'s treating physician.
Epistemonikos ID: 1039bc515fb869a4c5a9f18755d18ea83311e44d
First added on: May 21, 2024